FOXO Technologies Files Annual Report with Concerns

FOXO Technologies ( (FOXO) ) has issued an announcement.

On April 16, 2025, FOXO Technologies Inc. announced the filing of its Annual Report on Form 10-K for the year ending December 31, 2024. The report includes an audit opinion highlighting concerns about the company’s ability to continue as a going concern. Despite these challenges, FOXO completed acquisitions of Myrtle Recovery Centers, Inc. and Rennova Community Health, Inc. in 2024, positioning itself for growth in 2025.

Spark’s Take on FOXO Stock

According to Spark, TipRanks’ AI Analyst, FOXO is a Underperform.

FOXO Technologies faces significant financial challenges, including ongoing losses and high leverage, which weigh heavily on its overall stock score. Technical analysis suggests bearish trends, while valuation metrics highlight profitability issues. However, recent corporate actions offer some optimism for future stability and growth.

To see Spark’s full report on FOXO stock, click here.

More about FOXO Technologies

FOXO Technologies Inc. operates in the biotechnology industry and owns three subsidiaries: Rennova Community Health, Inc., which operates a critical access hospital in East Tennessee; Myrtle Recovery Centers, Inc., a behavioral health facility offering inpatient and outpatient services; and FOXO Labs, Inc., focused on developing technology and product solutions to improve human health and lifespan.

YTD Price Performance: -62.41%

Average Trading Volume: 7,477,750

Technical Sentiment Signal: Buy

Current Market Cap: $3.49M

See more data about FOXO stock on TipRanks’ Stock Analysis page.